India's COVID-19 case tally crossed the 43-lakh mark with a spike of 89,706 new cases and 1,115 deaths reported in the last 24 hours.
undefined
The total case tally stands at 43,70,129 including 8,97,394 active cases, 33,98,845 cureddischargedmigrated and 73,890 deaths, showed ministry of health data on Wednesday (September 9).
undefined
According to the health ministry, Maharashtra, Andhra Pradesh, Karnataka, Uttar Pradesh and Tamil Nadu account for 62% of total active coronavirus cases in the country.
undefined
Maharashtra, the worst-hit state on Tuesday reported 20,131 new COVID-19 cases, taking its tally to 9,43,772, while the death toll went up to 27,407 with 380 patients succumbing to the infection, state health department said.
undefined
Maharashtra accounts for 27% of the total active cases, Andhra Pradesh 11%, Karnataka 10.98%, Uttar Pradesh about 7%, and Tamil Nadu around 6%.
undefined
India has crossed the five-crore mark for sample testing of the novel coronavirus as of September 7, informed the Indian Council of Medical Research (ICMR) on Tuesday, adding that 10,98,621 samples were tested for the pathogen on Monday.
undefined
Phase-3 clinical trials of a coronavirus vaccine being developed by AstraZeneca, in collaboration with Oxford University, have been halted worldwide after one participant in England reported serious side-effects.
undefined
The clinical trials for the COVID-19 vaccine candidate developed by the University of Oxford, which was expected to start at PGIMER in Chandigarh, have been delayed by at least a week over safety approvals.
undefined